Search Results 1431-1440 of 18145 for monoclonal antibody

1. CNS Autoantibody and Inflammatory Marker Investigation in Catatonia - Mayo Clinic

   Clinical Trials · CNS Autoantibody and Inflammatory Marker Investigation in Catatonia · More about research at Mayo Clinic · Mayo Clinic Footer.

2. Clinical trials - Oncology (Medical)

   A Study of Hematopoiesis in Patients with Monoclonal ... Monoclonal B Cell Lymphocytosis (MBL) and B ... antibodies) treatment, CPI-naïve hepatocellular ...

3. Phase I Dose Escalation Study For BAY 1251152 In Patients With Advanced Cancer - Mayo Clinic

   Major surgery, significant trauma, wide-field radiotherapy, or therapy with monoclonal antibodies within 4 weeks before the first dose of study drug ...

4. Clinical trials - Oncology (Medical)

   The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

5. The ExTINGUISH Trial Of Inebilizumab In NMDAR Encephalitis (ExTINGUISH) - Mayo Clinic

   NMDAR encephalitis is a life‑threatening, antibody-mediated autoimmune disorder of the central nervous system. Standard of care includes high-dose ...

6. A Phase 2a Study Of TPN-101 In Patients With Progressive Supranuclear Palsy (PSP) - Mayo Clinic

   Receipt of an investigational immunomodulator or monoclonal antibody within 180 days (or 5 half-lives, whichever is longer) prior to Screening. Receipt of ...

7. Clinical trials - Oncology (Medical)

   ... antibody) * Olaparib (a type of PARP inhibitor). Benevolent Tumor Tissue Repository Fighting for the Legacy of our Young. Rochester, Minn. The aim of this ...

8. Study Of Pembrolizumab Combined With Decitabine And Pralatrexate In Peripheral T-cell Lymphoma And Cutaneous T-cell Lymphoma - Mayo Clinic

   Has had a prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior ... Has a known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies).

9. A Study Of The Effectiveness And Safety Of Pembrolizumab (MK-3475) For Women With Advanced Recurrent Ovarian Cancer - Mayo Clinic

   Has had prior anti-cancer monoclonal antibody (mAb), chemotherapy, targeted small molecule therapy, or radiation therapy within 4 weeks prior to the planned ...

10. SMAC Mimetic LCL161 Alone Or With Cyclophosphamide In Treating Patients With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

    Serum monoclonal protein ≥ 1.0 g/dL; ≥ 200 mg of monoclonal protein in the ... Monoclonal plasmacytosis ≥ 30% (evaluable disease); Measurable ...